1. Home
  2. CLSK vs RARE Comparison

CLSK vs RARE Comparison

Compare CLSK & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLSK
  • RARE
  • Stock Information
  • Founded
  • CLSK 1987
  • RARE 2010
  • Country
  • CLSK United States
  • RARE United States
  • Employees
  • CLSK N/A
  • RARE N/A
  • Industry
  • CLSK Finance: Consumer Services
  • RARE Biotechnology: Pharmaceutical Preparations
  • Sector
  • CLSK Finance
  • RARE Health Care
  • Exchange
  • CLSK Nasdaq
  • RARE Nasdaq
  • Market Cap
  • CLSK 2.6B
  • RARE 2.6B
  • IPO Year
  • CLSK N/A
  • RARE 2014
  • Fundamental
  • Price
  • CLSK $11.44
  • RARE $28.71
  • Analyst Decision
  • CLSK Strong Buy
  • RARE Strong Buy
  • Analyst Count
  • CLSK 9
  • RARE 14
  • Target Price
  • CLSK $20.66
  • RARE $86.64
  • AVG Volume (30 Days)
  • CLSK 18.8M
  • RARE 1.4M
  • Earning Date
  • CLSK 08-07-2025
  • RARE 11-04-2025
  • Dividend Yield
  • CLSK N/A
  • RARE N/A
  • EPS Growth
  • CLSK N/A
  • RARE N/A
  • EPS
  • CLSK 0.98
  • RARE N/A
  • Revenue
  • CLSK $631,937,000.00
  • RARE $610,159,000.00
  • Revenue This Year
  • CLSK $111.14
  • RARE $19.72
  • Revenue Next Year
  • CLSK $46.10
  • RARE $23.29
  • P/E Ratio
  • CLSK $11.64
  • RARE N/A
  • Revenue Growth
  • CLSK 84.66
  • RARE 26.77
  • 52 Week Low
  • CLSK $6.45
  • RARE $25.81
  • 52 Week High
  • CLSK $17.97
  • RARE $59.90
  • Technical
  • Relative Strength Index (RSI)
  • CLSK 68.05
  • RARE 39.94
  • Support Level
  • CLSK $9.81
  • RARE $28.96
  • Resistance Level
  • CLSK $10.54
  • RARE $31.80
  • Average True Range (ATR)
  • CLSK 0.59
  • RARE 1.00
  • MACD
  • CLSK 0.27
  • RARE -0.24
  • Stochastic Oscillator
  • CLSK 91.58
  • RARE 2.27

About CLSK CleanSpark Inc.

Cleanspark Inc is a bitcoin mining company. Through CleanSpark, Inc., and the Company's wholly owned subsidiaries, the company mines bitcoin. The company entered the bitcoin mining industry through its acquisition of ATL. Bitcoin mining is the sole reportable segment of the company.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Share on Social Networks: